. Author manuscript; available in PMC: 2022 Mar 4.

Published in final edited form as: SSM Ment Health. 2021 Oct 20;1:100034. doi: 10.1016/j.ssmmh.2021.100034

Table 3.

Association between internalized stigma (IARSS) and depressive symptom severity (HSCL) over successive intervals of HIV antiretroviral therapy adjusting for potential confounders, with IARSS score as a continuous exposure, and HSCL score as a continuous outcome (N = 454).

	b coefficient (95% CI)	P-value

Multivariable adjusted models^a

0–4 months	0.04 (0.02, 0.06)	0.001
4–8 months	0.03 (0.008, 0.05)	0.006
8–12 months	0.02 (0.001, 0.04)	0.04
12–16 months	0.03 (0.009, 0.05)	0.004
16–20 months	0.03 (0.005, 0.05)	0.01
20–24 months	0.02 (0.003, 0.04)	0.02
≥ 24 months	0.02 (−0.008, 0.04)	0.20

CI = confidence interval; HSCL = Hopkins Symptom Checklist; IARSS = Internalized AIDS-Related Stigma Scale.

each row represents the output of a multivariable regression model, with the cell displaying only the estimated association between internalized stigma (IARSS) and depression symptom severity (HSCL) adjusted for year of enrollment into cohort, age, gender, asset index quartile, CD4 count at baseline, educational level, and marital status.